You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 3, March 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Laser Surgery
 •Alert me on articles by topic

Medical, Laser, and Surgical Management of Inadvertent Cyclodialysis Cleft With Hypotony

Arch Ophthalmol. 2004;122:399-404.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Cyclodialysis cleft is the result of separation of the meridonal ciliary muscle fibers from the scleral spur,1 thereby providing a new drainage pathway of aqueous humor into the suprachoroidal space. Cyclodialysis has been used as a surgical option for aphakic glaucoma2 but more often occurs inadvertently during anterior segment surgery or because of blunt ocular trauma. The new drainage channel increases uveoscleral outflow and may result in chronic ocular hypotony. Choroidal effusion, cystoid macular edema, optic nerve edema, engorgement and stasis of retinal veins, retinal folds, shallow anterior chamber, and cataract are recognized complications of chronic ocular hypotony.

Medical management of inadvertent cyclodialysis cleft is a trial of topical 1% atropine sulfate for 6 to 8 weeks. Topical or systemic corticosteroid therapy is not indicated. If medical management is ineffective, noninvasive methods of cleft closure, such as argon laser photocoagulation to the cleft, should be attempted. Should conservative therapy fail, . . . [Full Text of this Article]

Report of Cases

Case 1

Case 2

Case 3

Case 4

Case 5

Case 6

Case 7


Comment
Ali Aminlari, MD; Christine E. Callahan, MD
Hershey, Pa

Corresponding author and reprints: Ali Aminlari, MD, Penn State University, Milton S. Hershey Medical Center, Department of Ophthalmology, PO Box 850, Hershey, PA 17033 (e-mail: aaminlari@psu.edu).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.